The Kappa Lambda Free Light Chains test aids healthcare professionals in detecting, diagnosing, and monitoring plasma cell disorders (dyscrasias), comprising primary amyloidosis, and in monitoring the effectiveness of treatment. This test is also utilized to aid in diagnosing a type of cancer called multiple myeloma.